Molecular and cellular effects of methotrexate
Author:
- 1 May 1999
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Rheumatology
- Vol. 11 (3) , 226-32
Abstract
In 1998, knowledge about the mechanisms of action of methotrexate (MTX) in immunoinflammatory disorders further increased. The most interesting results to date came from studies showing that most of the anti-inflammatory actions of MTX are mediated by adenosine, which may account for the profound effects of MTX on cytokines, cytokine inhibitors, and cell differentiation. Finally, potential novel pharmacologic strategies are discussed based on actual knowledge about the molecular and cellular actions of MTX.Keywords
This publication has 49 references indexed in Scilit:
- Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides.Journal of Clinical Investigation, 1998
- Inhibition of synoviocyte collagenase gene expression by adenosine receptor stimulationArthritis & Rheumatism, 1996
- The antiinflammatory effects of an adenosine kinase inhibitor are mediated by adenosineArthritis & Rheumatism, 1995
- METHOTREXATE ACTION IN RHEUMATOID ARTHRITIS: STIMULATION OF CYTOKINE INHIBITOR AND INHIBITION OF CHEMOKINE PRODUCTION BY PERIPHERAL BLOOD MONONUCLEAR CELLSRheumatology, 1995
- CIRCULATING CONCENTRATIONS AND PRODUCTION OF CYTOKINES AND SOLUBLE RECEPTORS IN RHEUMATOID ARTHRITIS PATIENTS: EFFECTS OF A SINGLE DOSE METHOTREXATERheumatology, 1994
- Serum levels of interleukin‐6 and tumour‐necrosis‐factor‐alpha are not correlated to disease activity in patients with rheumatoid arthritis after treatment with low‐dose methotrexateEuropean Journal of Clinical Investigation, 1994
- Acute and chronic suppression of leukotriene B4 synthesis EX vivo in neutrophils from patients with rheumatoid arthritis beginning treatment with methotrexateArthritis & Rheumatism, 1992
- Suppression of rheumatoid factor production by methotrexate in patients with rheumatoid arthritis: Evidence for differential influences of therapy and clinical status on IgM and IgA rheumatoid factor expressionArthritis & Rheumatism, 1990
- Dietary fish oil and olive oil supplementation in patients with Rheumatoid Arthritis clinical and immunologic effectsArthritis & Rheumatism, 1990
- Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low‐dose methotrexateArthritis & Rheumatism, 1989